NCT06850870
Door-Through-Door Companion Rideshare Technology for Individuals With Alzheimer's Disease and Related Dementias (AD/ADRD)
Active, Not Recruiting
PHASE1Ages 60+InterventionalSupportive careOnward Health, Inc
~120 participants
Updated 2026-07-21 on ClinicalTrials.gov
What's tested:Door-through-door companion rideshareCurb-to-curb rideshare services
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Appointment Adherence
Measured over 9 Months
Conditions
Where it's being run
1 sites across 1 statesCalifornia1
Study leadership
- Kimberly Wachter Petty, MBA · PRINCIPAL_INVESTIGATOR · Onward Health, Inc
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
All participants (or their surrogate) have the capacity to agree to allow Onward service for transportation;
have scheduled medical appointments at partner practices of Onward;
ages 60+
community-dwelling;
60 participants who self-reported cognitive problems, such as memory issue, or have mild cognitive impairment, subjective cognitive decline, or AD/ADRD diagnosis
Resides and attends appointments in the following San Francisco Bay Area Counties (San Francisco, Alameda, Contra Costa, Marin, San Mateo, Sonoma)
Exclusion
current enrollment in another transportation study;
already using any type of free or heavily subsized transportation service;
enrollees with comfort care only;
Not wheelchair bound, e.g. if using a wheelchair must be foldable and must be able to transfer
Transient, lacking consistent long term housing
Resides outside of the San Francisco Bay Area
What this trial measures
- Appointment Adherence9 Months
The rate of missed medical appointments (No shows and same day cancellations).